Investment analysts at HC Wainwright raised their Q2 2025 earnings per share estimates for Eton Pharmaceuticals in a report released on Thursday, January 23rd. HC Wainwright analyst S. Ramakanth now ...

Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the ...

Berl, S., Lajtha, A., and Waelsch, H., J. Neurochem. (in the press). Berl, S., and Waelsch, H., J. Neurochem., 3, 161 (1958), and unpublished methods.

After hours: February 11 at 4:00:09 p.m. EST Loading Chart for ETON ...

Pre-Market: 5:31:00 am GMT-5 Loading Chart for ETON ...